Potassium ChlorideCAS# 7447-40-7 |
- Posaconazole hydrate
Catalog No.:BCC4234
CAS No.:1198769-38-8
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 7447-40-7 | SDF | Download SDF |
PubChem ID | 4873 | Appearance | Powder |
Formula | KCl | M.Wt | 74.55 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 2000 mM in water | ||
Chemical Name | potassium;chloride | ||
SMILES | [Cl-].[K+] | ||
Standard InChIKey | WCUXLLCKKVVCTQ-UHFFFAOYSA-M | ||
Standard InChI | InChI=1S/ClH.K/h1H;/q;+1/p-1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Commonly used laboratory reagent |
Potassium Chloride Dilution Calculator
Potassium Chloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 13.4138 mL | 67.0691 mL | 134.1382 mL | 268.2763 mL | 335.3454 mL |
5 mM | 2.6828 mL | 13.4138 mL | 26.8276 mL | 53.6553 mL | 67.0691 mL |
10 mM | 1.3414 mL | 6.7069 mL | 13.4138 mL | 26.8276 mL | 33.5345 mL |
50 mM | 0.2683 mL | 1.3414 mL | 2.6828 mL | 5.3655 mL | 6.7069 mL |
100 mM | 0.1341 mL | 0.6707 mL | 1.3414 mL | 2.6828 mL | 3.3535 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Sauvagine
Catalog No.:BCC5792
CAS No.:74434-59-6
- Symlandine
Catalog No.:BCN1974
CAS No.:74410-74-5
- PAF (C16)
Catalog No.:BCC7522
CAS No.:74389-68-7
- Leuprolide Acetate
Catalog No.:BCC1701
CAS No.:74381-53-6
- 8-Geranyloxypsoralen
Catalog No.:BCN4296
CAS No.:7437-55-0
- 4-hydroxyephedrine hydrochloride
Catalog No.:BCC8103
CAS No.:7437-54-9
- Ent-16Α,17-Dihydroxy-19-Kauranoic Acid
Catalog No.:BCC9227
CAS No.:74365-74-5
- Chidamide
Catalog No.:BCC6445
CAS No.:743420-02-2
- (RS)-AMPA
Catalog No.:BCC6560
CAS No.:74341-63-2
- 4',4'''-Di-O-methylcupressuflavone
Catalog No.:BCN4295
CAS No.:74336-91-7
- Schisandrin A
Catalog No.:BCN5815
CAS No.:7432-28-2
- Z-Trp-OH
Catalog No.:BCC2750
CAS No.:7432-21-5
- Casegravol
Catalog No.:BCN4591
CAS No.:74474-76-3
- Alprostadil
Catalog No.:BCC4963
CAS No.:745-65-3
- MMAF
Catalog No.:BCC5144
CAS No.:745017-94-1
- Ivachtin
Catalog No.:BCC2357
CAS No.:745046-84-8
- UBP 296
Catalog No.:BCC7255
CAS No.:745055-86-1
- UBP 302
Catalog No.:BCC7256
CAS No.:745055-91-8
- Cristacarpin
Catalog No.:BCN3935
CAS No.:74515-47-2
- Isomedicarpin
Catalog No.:BCN4297
CAS No.:74560-05-7
- D-64131
Catalog No.:BCC1510
CAS No.:74588-78-6
- Rubiadin 1-methyl ether
Catalog No.:BCN4298
CAS No.:7460-43-7
- Tetrahydrocoptisine
Catalog No.:BCN2558
CAS No.:7461-02-1
- Tylosin tartrate
Catalog No.:BCC4875
CAS No.:74610-55-2
Hygroscopic properties of potassium chloride and its internal mixtures with organic compounds relevant to biomass burning aerosol particles.[Pubmed:28240258]
Sci Rep. 2017 Feb 27;7:43572.
While water uptake of aerosols exerts considerable impacts on climate, the effects of aerosol composition and potential interactions between species on hygroscopicity of atmospheric particles have not been fully characterized. The water uptake behaviors of Potassium Chloride and its internal mixtures with water soluble organic compounds (WSOCs) related to biomass burning aerosols including oxalic acid, levoglucosan and humic acid at different mass ratios were investigated using a hygroscopicity tandem differential mobility analyzer (HTDMA). Deliquescence points of KCl/organic mixtures were observed to occur at lower RH values and over a broader RH range eventually disappearing at high organic mass fractions. This leads to substantial under-prediction of water uptake at intermediate RH. Large discrepancies for water content between model predictions and measurements were observed for KCl aerosols with 75 wt% oxalic acid content, which is likely due to the formation of less hygroscopic potassium oxalate from interactions between KCl and oxalic acid without taken into account in the model methods. Our results also indicate strong influence of levoglucosan on hygroscopic behaviors of multicomponent mixed particles. These findings are important in further understanding the role of interactions between WSOCs and inorganic salt on hygroscopic behaviors and environmental effects of atmospheric particles.
New approach for cystic fibrosis diagnosis based on chloride/potassium ratio analyzed in non-invasively obtained skin-wipe sweat samples by capillary electrophoresis with contactless conductometric detection.[Pubmed:28357484]
Anal Bioanal Chem. 2017 May;409(14):3507-3514.
A new approach for sweat analysis used in cystic fibrosis (CF) diagnosis is proposed. It consists of a noninvasive skin-wipe sampling followed by analysis of target ions using capillary electrophoresis with contactless conductometric detection (C4D). The skin-wipe sampling consists of wiping a defined skin area with precleaned cotton swab moistened with 100 muL deionized water. The skin-wipe sample is then extracted for 3 min into 400 muL deionized water, and the extract is analyzed directly. The developed sampling method is cheap, simple, fast, and painless, and can replace the conventional pilocarpine-induced sweat chloride test commonly applied in CF diagnosis. The aqueous extract of the skin-wipe sample content is analyzed simultaneously by capillary electrophoresis with contactless conductometric detection using a double opposite end injection. A 20 mmol/L L-histidine/2-(N-morpholino)ethanesulfonic acid and 2 mmol/L 18-crown-6 at pH 6 electrolyte can separate all the major ions in less than 7 min. Skin-wipe sample extracts from 30 study participants-ten adult patients with CF (25-50 years old), ten pediatric patients with CF (1-15 years old), and ten healthy control individuals (1-18 years old)-were obtained and analyzed. From the analyzed ions in all samples, a significant difference between chloride and potassium concentrations was found in the CF patients and healthy controls. We propose the use of the Cl(-)/K(+) ratio rather than the absolute Cl(-) concentration and a cutoff value of 4 in skin-wipe sample extracts as an alternative to the conventional sweat chloride analysis. The proposed Cl(-)/K(+) ion ratio proved to be a more reliable indicator, is independent of the patient's age, and allows better differentiation between non-CF individuals and CF patients having intermediate values on the Cl(-) sweat test. Figure New approach for cystic fibrosis diagnosis based on skin-wipe sampling of forearm and analysis of ionic content (Cl(-)/K(+) ratio) in skin-wipe extracts by capillary electrophoresis with contactless conductometric detection.
An Isolable Potassium Salt of a Borasilene-Chloride Adduct.[Pubmed:28328112]
Angew Chem Int Ed Engl. 2017 Apr 10;56(16):4593-4597.
Among the variety of isolable compounds with multiple bonds involving silicon, examples of compounds that contain silicon-boron double bonds (borasilenes) still remain relatively rare. Herein, we report the synthesis of the potassium salt of a chloride adduct of borasilene 1 ([2](-) ), which was obtained as an orange crystalline solid. Single-crystal X-ray diffraction analysis and reactivity studies on [2](-) confirmed the double-bond character of the Si=B bond as well as the reduced Lewis acidity, which is due to the coordination of Cl(-) to the boron center. A thermal reaction of [2](-) afforded a bicyclic product by formal intramolecular C-H insertion across the Si=B bond of 1, which was corroborated by a theoretical study.
Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake.[Pubmed:28341239]
Kidney Int. 2017 Feb;91(2):402-411.
Dietary potassium intake is inversely related to blood pressure and mortality. Moreover, the sodium-chloride cotransporter (NCC) plays an important role in blood pressure regulation and urinary potassium excretion in response to potassium intake. Previously, it was shown that NCC is activated by the WNK4-SPAK cascade and dephosphorylated by protein phosphatase. However, the mechanism of NCC regulation with acute potassium intake is still unclear. To identify the molecular mechanism of NCC regulation in response to potassium intake, we used adult C57BL/6 mice fed a 1.7% potassium solution by oral gavage. We confirmed that acute potassium load rapidly dephosphorylated NCC, which was not dependent on the accompanying anions. Mice were treated with tacrolimus (calcineurin inhibitor) and W7 (calmodulin inhibitor) before the oral potassium loads. Dephosphorylation of NCC induced by potassium was significantly inhibited by both tacrolimus and W7 treatment. There was no significant difference in WNK4, OSR1, and SPAK expression after high potassium intake, even after tacrolimus and W7 treatment. Another phosphatase, protein phosphatase 1, and its endogenous inhibitor I-1 did not show a significant change after potassium intake. Hyperkaliuria, induced by high potassium intake, was significantly suppressed by tacrolimus treatment. Thus, calcineurin is activated by an acute potassium load, which rapidly dephosphorylates NCC, leading to increased urinary potassium excretion.